MARKET

ADMA

ADMA

Adma Biologics
NASDAQ
19.85
-0.26
-1.29%
After Hours: 19.69 -0.16 -0.80% 19:10 12/05 EST
OPEN
20.09
PREV CLOSE
20.11
HIGH
20.10
LOW
19.63
VOLUME
3.03M
TURNOVER
--
52 WEEK HIGH
25.67
52 WEEK LOW
13.50
MARKET CAP
4.72B
P/E (TTM)
23.42
1D
5D
1M
3M
1Y
5Y
1D
PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain
NASDAQ · 3d ago
MIRM Enrolls First Patient in Phase II Fragile X Syndrome Study
NASDAQ · 4d ago
Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet
NASDAQ · 5d ago
Weekly Report: what happened at ADMA last week (1124-1128)?
Weekly Report · 5d ago
ADMA Biologics Currently Up Seven Consecutive Days, On Track for Longest Winning Streak Since September 2024 -- Data Talk
Dow Jones · 11/26 19:06
Adma Biologics (ADMA) Upgraded to Buy: Here's What You Should Know
NASDAQ · 11/25 17:00
NVO Stock Down as Rybelsus Misses Goals in 2 Alzheimer's Studies
NASDAQ · 11/25 16:10
Biogen Inks Research Deal With Dayra to Boost Immunology Pipeline
NASDAQ · 11/25 15:43
More
About ADMA
ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The Company manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV (immune globulin intravenous, human-slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM (immune globulin intravenous, human) for the treatment of PI; and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.

Webull offers ADMA Biologics Inc stock information, including NASDAQ: ADMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADMA stock methods without spending real money on the virtual paper trading platform.